Skip to main content

Upregulation of Cytotoxic T‑cells in pediatric patients with Gaucher disease

Research Authors
Asmaa M. Zahran1, Khaled Saad 2*, Khalid I. Elsayh2, Madleen Adel A. Abdou3, Amir M. Abo‑Elgheet2, Esraa M. Eloseily2, Shaimaa M. Khalaf2, Shabaan Sror2, Faisal‑Alkhateeb Ahmad2, Amira Elhoufey4,5, Aliaa Ghandour6 & Naglaa S. Osman2
Research Date
Research Department
Research File
Research Journal
scientific report
Research Vol
12
Research Website
https://doi.org/10.1038/s41598-022-08843-4
Research Year
2022
Research_Pages
4977
Research Abstract

Cytotoxic (CD8) T-cells and natural killer (NK) cells have a significant immune function role. The
ongoing stimulation of immunity and the excessive release of proinflammatory cytokines observed
in pediatric patients with Gaucher disease (GD) can affect immune cells. Few studies have looked
at the proportion of cytotoxic CD8 T-cells and their subsets in children with GD. A prospective
case–control study was performed involving twenty pediatric patients with type 1 GD and twenty
healthy age-matched controls. All patients received regular enzyme replacement therapy (ERT) for
at least 6 months before the study. Complete blood count and flow cytometric analyses of CD8 T,
Tc1, Tc2, NK, and NK T-cells were performed. GD patients showed significantly increased of CD8 T,
Tc1 and significantly decreased NK cells frequencies when compared to healthy controls. However,
no significant difference in Tc2 and NK T-cells was found between the studied groups. GD patients on
regular ERT have increased CD8+ T-cell frequencies, predominantly Tc1, together with a reduction in
NK cells than in healthy controls. These crucial immunological changes may contribute to some extent
to the pathogenesis and the progression of GD.